Skip to content

Clinical trials

Overweight trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Country / region: Bulgaria Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20183
20221
20257
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Active, not recruiting5
Completed3
Not yet recruiting2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S7
Amgen2
Eli Lilly and Company2
Kailera2
Pfizer2
AstraZeneca1
BTL Industries Ltd.1
Fundació d'investigació Sanitària de les Illes Balears1
Harokopio University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity19
Overweight19
Diabetes Mellitus, Type 24
Diabetes Mellitus3
Nutrition Disorders2
Atherosclerosis1
Body Weight1
Colitis, Ulcerative1
Crohn Disease1
Endocrine System Diseases1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.